Progressive shifts in the gut microbiome reflect prediabetes and diabetes development in a treatment-naive Mexican cohort
Christian Diener, María de Lourdes Reyes‐Escogido, Lilia M. Jiménez-Ceja, Mariana G. Matus, Claudia Mercedes Gómez Navarro, Nathaniel D. Chu, Vivian Zhong, Maria Elizabeth Tejero, Eric J. Alm, Osbaldo Reséndis-Antonio, Rodolfo Guardado‐Mendoza
The paper identifies gut microbiome biomarkers associated with T2D progression in a Mexican cohort and shows metformin treatment reverses these changes.
Frontiers in Endocrinology · Jan 8, 2021Peer-reviewedSystems Biology